###begin article-title 0
Muscarinic acetylcholine receptor 1 gene polymorphisms associated with high myopia
###end article-title 0
###begin p 1
The first two authors contributed equally to this publication.
###end p 1
###begin title 2
Purpose
###end title 2
###begin p 3
###xml 533 541 533 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> (CHRM1)</italic>
###xml 80 85 <span type="species:ncbi:9606">human</span>
Numerous studies, including those using animal models of myopia development and human clinical trials, have shown that the non-selective muscarinic antagonist atropine is effective in preventing the axial elongation that leads to myopia development. Among all of the muscarinic acetylcholine receptors (mAChRs), mAChR 1 (M1) was the most effective in preventing myopic eye change. Our specific aim in this study was to examine the association between high myopia and polymorphisms within the muscarinic acetylcholine receptors 1 gene (CHRM1).
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 459 464 459 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHRM1</italic>
###xml 471 476 471 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHRM1</italic>
###xml 483 488 483 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHRM1</italic>
###xml 499 504 499 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHRM1</italic>
###xml 4 16 <span type="species:ncbi:9606">participants</span>
The participants comprised of a high myopia group (n=194; age range, 17-24 years) having a myopic spherical equivalent greater than 6.5 diopters (D) and a control group (n=109; age range, 17-25 years) having a myopic spherical equivalent less than 0.5 D. Genotyping was performed using an assay-on-demand allelic discrimination assay. Polymerase chain reaction (PCR) was performed using 96 well plates on a thermal cycler. The polymorphisms detected were S1 (CHRM1), S2 (CHRM1), S3 (CHRM1), and S4 (CHRM1).
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 121 123 121 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 135 137 135 137 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-8</sup>
###xml 348 353 348 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHRM1</italic>
###xml 527 529 527 529 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
There was a significant difference in the distribution of S2 and S4 between the high myopia and control groups (p=2.40x10-6 and 2.38x10-8, respectively). The odds ratios of AA genotype of S2 and GG genotype of S4 were both 0.08 (95% confidence interval [CI]: 0.02-0.29 and 0.02-0.36, respectively). Logistic regression test revealed S1, S2, and S4 CHRM1 as all being significant in the development of high myopia. Moreover, the distributions of haplotype 4 (Ht4; C/A/A/A) differed significantly between the two groups (p=3.4x10-5, odds ratio: 0.1, 95% CI: 0.03-0.34).
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
###xml 56 61 56 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHRM1</italic>
###xml 140 145 140 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHRM1</italic>
Our results suggest that the S2 and S4 polymorphisms of CHRM1 are associated with susceptibility for developing high myopia. S1, S2, and S4 CHRM1 had a co-operative association with high myopia.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 161 162 161 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 163 164 163 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 249 250 249 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 470 471 470 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 472 473 472 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 785 790 785 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHRM1</italic>
###xml 791 796 791 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHRM5</italic>
###xml 914 916 914 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 917 919 917 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 1243 1244 1243 1244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 1245 1247 1245 1247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 1248 1250 1248 1250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 1410 1411 1410 1411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 1412 1414 1412 1414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 1415 1417 1415 1417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 2099 2101 2099 2101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 476 481 <span type="species:ncbi:9606">Human</span>
###xml 938 949 <span type="species:ncbi:10141">guinea pigs</span>
Clinically significant refractive errors are the most common type of visual disorders. Myopia affects more than half of the young adult population in the world [1-3]. In Asian countries, the prevalence of myopia has approached epidemic proportions [4]. A range of animal models of myopia development have demonstrated that the non-selective muscarinic acetylcholine antagonist, atropine, is effective in preventing the axial elongation that leads to myopia development [5-9]. Human clinical trials have also shown an effectiveness of daily atropine administration in reducing the progression of myopia. The muscarinic acetylcholine receptors (mAChRs) are a group of neurotransmitter proteins belonging to the seven transmembrane superfamily of receptors. Five distinct receptor genes (CHRM1-CHRM5) have been cloned, each encoding a muscarinic receptor protein 1-5 (M1-M5) with specific pharmacological properties [10-12]. In the study of guinea pigs, M1 and M4 subtypes were found to be significantly increased in the posterior sclera of form-deprived myopic eyes. Studies of the individual muscarinic antagonists had revealed that M1 selective pirenzepine and M2/M4 selective himbacine were effective in inhibiting the development of myopia [8,13,14]. Pirenzepine, an M1 selective antagonist, is effective in preventing the progression of myopia in a dose-dependent manner in both mammalian and avian models [8,13,15]. According to the previous studies, we understood that among all mAChRs, M1, M2, and M4 might have the most important roles in the "stop" signal of myopic progression. In vitro studies had found that mAChR antagonists inhibit proliferation and matrix synthesis of the cartilaginous sclera. There was a rank order of the selective antagonists in the function of reducing incorporation of sulfate into glycosaminoglycans (GAGs) by chondrocytes. The rank of potency was M1 (pirenzepine-telenzepine) > Ml and M3 (4-diphenylacetoxy-N-methylpiperidine methiodide [4-DAMP]) > M2 (gallamine). The ranking suggests that the Ml subtype is the most dominant type to regulate scleral growth [16].
###end p 11
###begin p 12
###xml 154 156 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 257 259 257 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 477 479 477 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 480 482 480 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 622 624 622 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 805 813 805 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> (CHRM1)</italic>
###xml 467 475 <span type="species:ncbi:9606">children</span>
Many studies have suggested that myopia is a complex disease with multiple causes including the interaction of multiple genes with environmental stimuli [17]. Therefore, to understand myopia, it is necessary to take both genes and environment into account [17]. There is evidence supporting the premise that myopia and refractive errors are in large part genetically determined. This comes from twin studies and from studies of refractive errors in parents and their children [18,19]. A well conducted study has shown that refractive errors were much more strongly correlated in monozygotic twins than in dizygotic twins [19]. In the present study, we investigated the association of genetic polymorphisms in M1 and high myopia. The gene encoding the M1 receptor, muscarinic acetylcholine receptors 1 gene (CHRM1), is localized to 11q13. Four genetic polymorphisms were selected using , genotypes were analyzed within  and tag SNPs were selected using the  function. The polymorphisms were  in the 3'UTR and , , and  in the intron.
###end p 12
###begin title 13
Methods
###end title 13
###begin title 14
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients
###end title 14
###begin p 15
###xml 100 112 <span type="species:ncbi:9606">participants</span>
###xml 189 201 <span type="species:ncbi:9606">participants</span>
###xml 314 326 <span type="species:ncbi:9606">participants</span>
###xml 851 859 <span type="species:ncbi:9606">Patients</span>
###xml 1202 1207 <span type="species:ncbi:9606">human</span>
###xml 1257 1269 <span type="species:ncbi:9606">participants</span>
###xml 1359 1371 <span type="species:ncbi:9606">participants</span>
###xml 1721 1729 <span type="species:ncbi:9606">Patients</span>
Between February to November 2004, we measured the refractive error in 3,000 volunteers. All of the participants were medical students, unrelated, and Taiwan-born Han Chinese. The enrolled participants in this study were aged 16-25 years (mean age of 18+/-3.2 years), and the male to female ratio was 1.8:1.0. All participants had a visual acuity with distance correction of 0.2 logMAR (20/32) or better. Refractive error was measured in diopters (D) and determined by the mean spherical equivalent (SE) of the two eyes of each individual after administering one drop of cycloplegic drug (1% mydriacyl; Alcon, Berlin, Germany). Individuals with myopia greater than or equal to 6.5 D (both eyes) were included in the high myopia group, and those with myopia less than 0.5 D and hyperopia less than 1.0 D (both eyes) were included in the control group. Patients with astigmatism with a refractive error more negative than -0.75 D were excluded from the study since it would alter the results of SE. The study was reviewed by the ethics committee of the China Medical University Hospital (Taichung, Taiwan) and performed in accordance with the tenets of the Declaration of Helsinki for research involving human subjects. Informed consent was obtained from all participants. A comprehensive ophthalmic examination and blood collection were performed. None of the participants had ocular disease or insult such as retinopathy, prematurity, neonatal problems, a history of genetic disease, and connective tissue disorders associated with myopia such as Strickler or Marfan syndromes. Clinical examinations included visual acuity, refraction error, slit-lamp examination, ocular movements, intraocular pressure, and fundoscopy. Patients with organic eye disease, a history or evidence of intraocular surgery, history of cataract, glaucoma, retinal disorders, or laser treatment were excluded. As with all data collection procedures, auto-refraction (Auto-refractor/auto-keratometer [ARK 700A; Nikon, Tokyo, Japan]) was conducted on both eyes by experienced optometrists who were trained and certified on the study protocols. Refractive data, sphere (s), negative cylinder (c), and axis measurements were analyzed by calculating SEM refractive error.
###end p 15
###begin title 16
Genotype determinations
###end title 16
###begin p 17
###xml 435 436 435 436 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 528 529 526 527 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1181 1186 1153 1158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHRM1</italic>
###xml 1193 1198 1165 1170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHRM1</italic>
###xml 1205 1210 1177 1182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHRM1</italic>
###xml 1221 1226 1193 1198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHRM1</italic>
###xml 1416 1418 1388 1390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 172 177 <span type="species:ncbi:9606">human</span>
To select the most representative SNPs to capture the majority genetic variation, SNP genotype information was downloaded in December, 2007 from the  (haplotype map of the human genome project) HCB (Han Chinese in Beijing, China) or JPN (Japanese) population from an extended 30Kb region of Chromosome 11.  genotypes were analyzed within  and Tag SNPs were selected using the  function. Four tag SNPs were selected for each gene with r2>/=0.80 to capture 80% of genotype information in the region. The average tag SNP was with r2=0.901. Genotyping was achieved using an assay-on-demand allelic discrimination assay and a detection system according to the manufacturer's instructions (Applied Biosystems Co, Foster City, CA). The polymerase chain reaction (PCR) reaction contained 10 ng of genomic DNA, 10 mul TaqMan master mix, and 0.125 mul of 40X assay mix. PCR was performed using 96 well plates on a thermal cycler (ABI 9700; Applied Biosystems). Reaction conditions were 50 degreesC for 2 min and 95 degreesC for 10 min followed by 40 cycles of 95 degreesC for 15 s and 60 degreesC for 1 min. Four polymorphisms met the criteria and were selected in this study. They were S1 (CHRM1), S2 (CHRM1), S3 (CHRM1), and S4 (CHRM1, ). Haplotypes were inferred from unphased genotype data using the Bayesian statistical method available in the software program, . All five SNPs were analyzed with the Phase 2.1 software [20].
###end p 17
###begin title 18
Statistical analysis
###end title 18
###begin p 19
###xml 126 127 124 125 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 510 512 508 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 604 605 600 601 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 612 614 608 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
Genotypes were obtained by direct counting with subsequent calculation of allele frequencies. Data were analyzed using the chi2 test or Fisher's exact test, and p values were calculated using the Minitab program (Minitab Inc., San Jose,CA). A p value less than 0.05 was considered statistically significant. The odds ratios (OR) and the corresponding 95% confidence intervals (CI) were calculated for associations concerning allele and genotype. Bonferroni corrections for multiple comparisons were performed [21]. All of the detected SNPs were assessed for Hardy-Weinberg equilibrium (HWE) using the chi2 test [22]. Stepwise logistic regression was used to determine if any one accounted for the effects of others. This was performed using the STATA package (version 8.2; Stata Corp., College Station, TX).
###end p 19
###begin title 20
Results
###end title 20
###begin p 21
###xml 403 410 401 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 605 612 603 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 618 623 616 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHRM1</italic>
###xml 630 635 628 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHRM1</italic>
###xml 642 647 640 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHRM1</italic>
###xml 658 663 656 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHRM1</italic>
###xml 700 705 698 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHRM1</italic>
###xml 776 783 774 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 865 870 863 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHRM1</italic>
###xml 871 871 869 869 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"/>
###xml 934 935 932 933 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 943 945 941 943 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-6</sup>
###xml 1000 1007 998 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 1012 1019 1010 1017 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 1030 1035 1028 1033 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHRM1</italic>
###xml 1223 1230 1221 1228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 1386 1393 1384 1391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 1476 1481 1474 1479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHRM1</italic>
###xml 1506 1508 1504 1506 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 2023 2030 2021 2028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 2193 2200 2191 2198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 2211 2216 2209 2214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHRM1</italic>
###xml 2648 2653 2646 2651 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHRM1</italic>
###xml 2744 2751 2742 2749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 2756 2763 2754 2761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 2885 2890 2883 2888 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHRM1</italic>
###xml 2936 2941 2934 2939 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHRM1</italic>
###xml 2999 3006 2997 3004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 3011 3018 3009 3016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 446 454 <span type="species:ncbi:9606">patients</span>
###xml 904 912 <span type="species:ncbi:9606">patients</span>
Volunteers enrolled in this study were on the basis of the following data: age, 16-25 years (mean, 18+/-3.3 years); male-to-female ratio, 1.48:1.0; mean axial length (AXL), 24.8 mm; and mean spherical equivalent (SE), -4.5D. There were no significant difference between the control and cases groups with respect to age, gender, cornea diopter (CD), anterior chamber depth (ACD), and LT (lens thickness; Table 1). The study group comprised of 194 patients with high myopia, and the control group consisted of 109 individuals with normal eyes. Four polymorphisms selected for this study are as described in Table 2: S1 (CHRM1), S2 (CHRM1), S3 (CHRM1), and S4 (CHRM1). The genotype distributions of the CHRM1 polymorphism for both the high myopia group and controls are shown in Table 2. There was significant difference in genotype and allele distribution of the S2 (CHRM1)polymorphism between high myopia patients and normal controls (p=2.40x10-6 and 0.004, respectively) after Bonferroni correction (Table 2 and Table 3). For S2 (CHRM1), the genotype frequencies of G/G, A/G, and A/A were 74.74%, 23.71%, and 1.55%, respectively, in the high myopia group and 69.72%, 12.84%, and 17.43%, respectively, in the control group (Table 3). The allelic frequency of G and A was 86.60% and13.40%, respectively, in the high myopia group and 76.15% and 23.85%, respectively, in the control group (Table 2). There was also a significant difference in the genotype distribution of the S4 (CHRM1) polymorphism (p=2.38x10-8 after Bonferroni correction) with the genotype frequencies of A/A, A/G, and G/G being 76.80%, 22.16%, and 1.03%, respectively, in the high myopia group and 83.49%, 2.75%, and 13.76%, respectively, in the control group. The odds ratios for an association with the S4 genotype were 8.75 (95% CI: 2.64-29.04) for A/G and 0.08 (95% CI: 0.02-0.36) for G/G. However, there were no significant differences in the distribution of S4 alleles between the high myopia and control groups (p=1.164 after Bonferroni correction; Table 2). The frequencies of S4 alleles A and G were 87.89% and 12.11%, respectively, in the high myopia group and 84.86% and 15.14%, respectively, in the control group (Table 2). For S1 (CHRM1), the frequencies of genotypes G/G, A/G, and A/A were 96.39%, 3.09%, and 0.52%, respectively, in the high myopia group and 97.25%, 2.75%, and 0%, respectively, in the control group. The frequencies of the G and A alleles were 97.94% and 2.06%, respectively, in the high myopia group and 98.62% and 1.38%, respectively, in the control group. There were no significant differences in the genotype and allele distributions of the S1 (CHRM1) polymorphism between the high myopia and control groups (p=2.96 and 2.176, respectively; Table 2 and Table 3). There were also no significant differences in the genotype distributions or allele frequencies of the S3 polymorphism (CHRM1) between the two groups. The p values of S3 (CHRM1) genotype and allele were p=0.12 and 3.98, respectively (Table 2 and Table 3).
###end p 21
###begin title 22
Characteristics of the study subjects and the partial correlation between spherical equivalent and other ocular components.
###end title 22
###begin p 23
SE: spherical equivalent (spherical equivalent equal to the sphere plus 1/2 the cylinder) spherical equivalent, AXL: axial length, CD: cornea diopter, ACD: anterior chamber depth, LT: lens thickness.
###end p 23
###begin title 24
###xml 46 51 46 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHRM1</italic>
Association between genotype distributions of CHRM1 polymorphisms and individuals with high myopia.
###end title 24
###begin p 25
###xml 155 156 155 156 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">#</sup>
###xml 163 164 161 162 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 298 301 296 299 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> ##</sup>
Genotype frequencies were compared between individuals with myopia greater than 6.00 D and less than 0.5 D. The asterisk indicates CI=confidence interval. #The chi2 test or Fisher's exact test was performed to obtain the p value. It was considered statistically significant if p was less than 0.05. ##Cp-value, p-value corrected by Bonferroni correction.
###end p 25
###begin title 26
###xml 43 48 43 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHRM1</italic>
Association between allelic frequencies of CHRM1 polymorphisms and individuals with high myopia.
###end title 26
###begin p 27
###xml 161 162 161 162 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">#</sup>
###xml 169 170 167 168 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 305 307 303 305 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">##</sup>
The frequencies of alleles were compared between individuals with myopia greater than 6.00 D and less than 0.5 D. The asterisk indicates CI=confidence interval. #The chi2 test or Fisher's exact test was performed to obtain the p value. It was considered statistically significant if p was less than 0.05. ##Cp-value, p value corrected by Bonferroni correction.
###end p 27
###begin p 28
###xml 64 71 64 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4</xref>
###xml 305 307 305 307 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 477 484 477 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4</xref>
Moreover, we selected four haplotypes by phase software v2.1.1 (Table 4). The haplotypes distributions of the Ht1 (G/G/A/A), Ht2 (G/G/G/A), Ht3 (G/A/A/G), and Ht4 (C/A/A/A) were also compared between the two groups. The haplotype Ht4 (C/A/A/A) was significantly difference between the two groups (p=3.4x10-5, OR: 0.1, 95% CI: 0.03-0.34). The haplotypes frequencies of Ht1, Ht2, and Ht3 did not differ significantly between the two groups (p=0.258, 0.6, and 1.56, respectively; Table 4).
###end p 28
###begin title 29
###xml 69 74 69 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHRM1</italic>
Odds ratios and 95% confidence intervals for the association between CHRM1 haplotypes and myopia.
###end title 29
###begin p 30
###xml 61 66 61 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHRM1</italic>
###xml 227 229 225 227 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sup>
###xml 729 730 727 728 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">#</sup>
###xml 737 738 733 734 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 969 971 965 967 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">##</sup>
###xml 823 829 <span type="species:ncbi:9606">people</span>
The asterisk indicates the order of polymorphisms comprising CHRM1 haplotypes: , , , and . The haplotypes were identified by the Bayesian statistical method available in the program, Phase 2.1. The double asterisk means the chi2 test (2x2 table) was performed to obtain the p value. The number of haplotypes in eyes with myopia greater than or equal to 6.0 D and less than or equal to 0.5 D with Ht1 was compared with the number of haplotypes in eyes with myopia greater than or equal to 6.0 D and less than or equal to 0.5 D without Ht1. A p value of less than 0.05 was considered statistically significant. Percentages may not add up to 100% because of the presence of rare haplotypes (below 0.3%) not presented in this table. #The chi2 test or Fisher's exact test was performed to obtain the p-value. The percentages of people with and without HT1 were compared between myopia and control groups. It was considered statistically significant if p was less than 0.05. ##Cp-value, p-value corrected by Bonferroni correction. The triple asterisk indicates CI=confidence interval.
###end p 30
###begin p 31
###xml 90 97 90 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t5">Table 5</xref>
###xml 335 342 335 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t5">Table 5</xref>
A logistic regression was used to determine the strength of association of the four SNPs (Table 5) with high myopia. Significant associations were found by the backward stepwise procedure for all SNPs except S3 (p=0.9219). S2 had the highest degree of association in the model (p=0.000) followed by S4 (p=0.002) and then S1 (p=0.031) (Table 5). In the test of HWE, there were departures from HWE for S1 in both the control and high myopia groups (p=0.048 and 0.023, respectively) and for S2 in the control group (p=0.012). The S3 and S4 polymorphisms were both in HWE.
###end p 31
###begin title 32
The main effects of SNPs by stepwise logistic regression procedure.
###end title 32
###begin p 33
###xml 74 79 74 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHRM1</italic>
###xml 85 90 85 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHRM1</italic>
###xml 95 101 95 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> CHRM1</italic>
###xml 107 112 107 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHRM1</italic>
Four polymorphisms were selected in this study and we defined them as S1: CHRM1, S2: CHRM1, S3: CHRM1, S4: CHRM1.
###end p 33
###begin title 34
Discussion
###end title 34
###begin p 35
###xml 145 147 145 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 148 150 148 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 182 184 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 187 190 187 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGF</italic>
###xml 225 229 225 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PAX6</italic>
###xml 260 266 260 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL1A1</italic>
###xml 296 298 296 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
###xml 564 566 564 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
###xml 567 569 567 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r31">31</xref>
###xml 872 884 <span type="species:ncbi:9606">participants</span>
Genetic studies have uncovered some polymorphisms, and separate loci are correlated with high myopia including those on chromosomes 18p and 12q [23,24] and on the genes of myocilin [25], TGF (transforming growth factor) [26],PAX6 (paired box gene 6) [27], and COL1A1 (collagen, type I, alpha 1) [26]. This indicates that there is a genetic predisposition to developing high myopia. However, no one gene can be solely responsible for the development of myopia, especially considering the wide variability in the prevalence of myopia across different ethnic groups [27-31]. The mechanisms by which myopia develops are further obscured by the uncertainty regarding the role of environmental factors. There is a higher prevalence of myopia among individuals with higher education levels than among members of the general population. Therefore, medical students were chosen as participants in the present study. Because both the high myopia and control groups constituted medical students, we believed that the bias associated with environmental influences would be minimal.
###end p 35
###begin p 36
###xml 205 207 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
###xml 208 210 208 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r28">28</xref>
###xml 363 365 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 556 558 556 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 559 561 559 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 897 898 897 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 899 900 899 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 901 903 901 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 904 906 904 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 1082 1084 1082 1084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 31 39 <span type="species:ncbi:9606">patients</span>
Clinical trials in school-aged patients have shown the effectiveness of daily atropine administration, which reduces the progression of myopia by approximately 60% at least in the first year of treatment [27,28]. The effect of atropine was suspected by depression of neuronal activity and leads to an increase in the general release of retinal neurotransmitters [22]. Furthermore, there is evidence that pirenzepine and himbacine inhibit myopia in a dose-dependent fashion, suggesting that these drugs mediate their effects through a receptoral mechanism [13,14]. Different muscarinic antagonists have been investigated for their individual effectiveness in reducing myopia. The efficacy of atropine, pirenzepine (M1 selective antagonist), himbacine (M4/M2 selective antagonist), and the nonselective muscarinic antagonist, oxyphenonium, were all effective in the inhibition of myopic eye growth [8,9,13,14], but individual mechanisms were still unknown. Since the results of an in vitro study suggest that the Ml mAChR subtype is most likely involved in regulating scleral growth [16], we selected it as the target gene in this study.
###end p 36
###begin p 37
###xml 105 110 105 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHRM1</italic>
###xml 116 121 116 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHRM1</italic>
###xml 131 136 131 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHRM1</italic>
###xml 264 269 264 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHRM1</italic>
###xml 296 301 296 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHRM1</italic>
###xml 325 330 325 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHRM1</italic>
###xml 1268 1270 1268 1270 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
With stepwise logistic regression, we found an association between three of the mAChR polymorphisms (S1: CHRM1, S2: CHRM1, and S4: CHRM1) and high myopia. No association was found for S3 (). The mAChR polymorphism most strongly associated with high myopia was S2 (CHRM1; p=0.000) followed by S4 (CHRM1; p=0.002) and then S1 (CHRM1; p=0.031). This was compatible with the genotype study. The frequencies of the AA genotype of S2 and the GG genotype of S4 were significantly less in the control group than in the study group, that is, they had protective effects of subjects suffering from high myopia (OR for both: 0.08; 95% CI: 0.02-0.29 and 0.02-0.36, respectively). Allele analysis revealed that the "A" allele of S2 had a significant protective effect against the development of high myopia (p=0.004; OR: 0.49; 95% CI: 0.32-0.76). However, the distribution of the "G" allele of S4 was not significantly different between the high myopia and control groups. These data indicate that the "GG" homologous genotype of S4 protects against the development of high myopia, and this function did not establish when only one "G" allele existed. Moreover, we observed that the frequencies of the haplotype Ht4 (G/A/A/A) differed significantly between the two groups (p=3.4x10-5). The Ht4 haplotype occurred more often in the control group than in the high myopia group (7.3% and 0.34%, respectively). The Ht4 haplotype might play a role in preventing the development of high myopia (OR: 0.1, 95% CI: 0.03-0.34). In conclusion, S1, S2, and S4 co-contributed to the genetic background of high myopia.
###end p 37
###begin p 38
###xml 1062 1067 1062 1067 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHRM1</italic>
###xml 1380 1382 1380 1382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r32">32</xref>
###xml 1730 1732 1730 1732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r32">32</xref>
###xml 1154 1162 <span type="species:ncbi:9606">patients</span>
Our study design has strengths and limitations. We screened a large number of study subjects, and our study population was relatively homogenous in terms of ethnicity, geographic location, and age. The limitation was that the target polymorphisms detected in this study were in the 3'UTR and in the intron. These polymorphisms might contribute to the physiologic function insignificantly. 3'UTR may alter the RNA stability and/or its translational efficiency, and the intron may alter mRNA splicing. All these implications should be confirmed by experimental data. We minimized errors in genotyping and validated our findings by repeating the genotyping analysis several times and obtaining consistent results. Therefore, occurrence of genotyping errors in this study was kept to a minimum. In the HWE test, however, two of the SNPs considered in our study were not in HWE. The deviations from HWE might be a sign of mutation and may increase possible association with myopia. This disequilibrium became other evidence of the association of the polymorphisms in CHRM1 with high myopia. Moreover, we tried to trace the ancestry background of controls and patients. Eighty-five percent are of Minnan descendants, 5% of them are Hakka descendants, and the remaining 10% are a mixed population of Minnan, Hakka, and Canton descendants. According to the paper published by Pan et al. [32], they mentioned that the SNP profiles in the major histocompatibility complex (MHC) region (6p21.3) showed no significant difference among Minnan descendants, Hakka descendants and mixed population of Minnan and Hakka descendants, which indicate the homogeneity of the population. Thus population stratification should not produce in this study [32].
###end p 38
###begin p 39
###xml 63 68 63 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHRM1</italic>
###xml 492 497 492 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHRM1</italic>
###xml 1184 1189 1184 1189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHRM1</italic>
###xml 1191 1196 1191 1196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHRM4</italic>
###xml 269 281 <span type="species:ncbi:9606">participants</span>
###xml 423 435 <span type="species:ncbi:9606">participants</span>
In the future, further studies are needed to confirm a role of CHRM1 in high myopia. Indeed, we intend to replicate the present study in a separate population group such as a non-student sample. We also plan to analyze the genotypes of the parents of the highly myopic participants of the current study to minimize bias. Further, we intend to analyze data across the spectrum of refractive error as obtained from all 3,000 participants screened to further understand the relationship between CHRM1 and the severity of myopia. Complex diseases such as diabetes, cancer, asthma, and arthritis are probably caused by subtle changes in multiple genes combined with environmental and lifestyle factors. Myopia is considered a complex and multigenic disease involving several overlapping signaling pathways, each mediated by a group of distinct genetic profiles. Therefore, studying genetic polymorphisms that are related to the mechanisms of myopia can help to further clarify the relationship between genetics and myopia. The discovery of associations between myopia and various genetic markers has helped increase the knowledge needed for the prevention and treatment of myopia. As with CHRM1, CHRM4 encodes a receptor important in the progression of myopia and also needs to be investigated.
###end p 39
###begin title 40
Acknowledgments
###end title 40
###begin p 41
This study was supported by grants from the China Medical University Hospital and from the National Science Council, Taiwan (NSC 96-2628-B-039-002-MY3).
###end p 41
###begin title 42
References
###end title 42
###begin article-title 43
Race, culture and Myopia in 110,236 young Singaporean males.
###end article-title 43
###begin article-title 44
Prevalence of myopia in a sample of Greek students.
###end article-title 44
###begin article-title 45
The increasing prevalence of myopia: implications for Australia.
###end article-title 45
###begin article-title 46
Myopia in Singapore: taking a public health approach.
###end article-title 46
###begin article-title 47
Atropine affects lid suture myopia development.
###end article-title 47
###begin article-title 48
###xml 82 96 <span type="species:ncbi:9544">rhesus monkeys</span>
Effects of muscarinic cholinergic receptor antagonists on postnatal eye growth of rhesus monkeys.
###end article-title 48
###begin article-title 49
Atropine reduces experimental myopia and eye enlargement via a nonaccommodative mechanism.
###end article-title 49
###begin article-title 50
###xml 46 51 <span type="species:ncbi:9031">chick</span>
Muscarinic antagonist effects on experimental chick myopia.
###end article-title 50
###begin article-title 51
Variable effects of previously untested muscarinic receptor antagonists on experimental myopia.
###end article-title 51
###begin article-title 52
Molecular properties of the muscarinic acetylcholine receptor.
###end article-title 52
###begin article-title 53
International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors.
###end article-title 53
###begin article-title 54
###xml 95 100 <span type="species:ncbi:9606">human</span>
Distinct primary structures, ligand-binding properties and tissue- specific expression of four human muscarinic acetylcholine receptors.
###end article-title 54
###begin article-title 55
Pirenzepine prevents form deprivation myopia in a dose dependent manner.
###end article-title 55
###begin article-title 56
Inhibition of myopia development in chicks using himbacine: a role for M4 receptors?
###end article-title 56
###begin article-title 57
###xml 83 93 <span type="species:ncbi:9395">tree shrew</span>
The M1 muscarinic antagonist pirenzepine reduces myopia and eye enlargement in the tree shrew.
###end article-title 57
###begin article-title 58
###xml 54 59 <span type="species:ncbi:9031">Chick</span>
Muscarinic Acetylcholine Receptor Antagonists Inhibit Chick Scleral Chondrocytes.
###end article-title 58
###begin article-title 59
Interactions of genes and environment in myopia.
###end article-title 59
###begin article-title 60
The importance of genes and environment for ocular refraction and its determiners: a population based study among 20-45 year old twins.
###end article-title 60
###begin article-title 61
Genes and environment in refractive error: the twin eye study.
###end article-title 61
###begin article-title 62
Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation.
###end article-title 62
###begin article-title 63
Assessment of TGIF as a candidate gene for myopia.
###end article-title 63
###begin article-title 64
A second locus for familial high myopia maps to chromosome 12q.
###end article-title 64
###begin article-title 65
Linkage Analysis of the Genetic Loci for High Myopia on 18p, 12q, and 17q in 51 U.K. Families.
###end article-title 65
###begin article-title 66
Linkage and association of myocilin (MYOC) polymorphisms with high myopia in a Chinese population.
###end article-title 66
###begin article-title 67
The COL1A1 gene and high myopia susceptibility in Japanese.
###end article-title 67
###begin article-title 68
The effect of atropine on myopia.
###end article-title 68
###begin article-title 69
Prevention of myopia progression with 0.05% atropine solution.
###end article-title 69
###begin article-title 70
Variable effects of previously untested muscarinic receptor antagonists on experimental myopia.
###end article-title 70
###begin article-title 71
###xml 100 105 <span type="species:ncbi:9031">chick</span>
Effects of atropine on refractive development, dopamine release, and slow retinal potentials in the chick.
###end article-title 71
###begin article-title 72
Genetic and environmental effects on oculometric traits.
###end article-title 72
###begin article-title 73
Han Chinese cell and genome bank in Taiwan: purpose, design and ethical considerations.
###end article-title 73

